| 362 | 2 | 434 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 比较药物流产与手术流产临床选择情况及两种方法的完全流产率、不良反应及近期并发症发生率。方法 基于国家卫生健康委科学技术研究所自2019年建立并持续至今的“人工流产女性生育风险前瞻性队列”中2019—2022年纳入的部分研究对象资料,通过对早期人工流产女性的基线数据收集和持续随访,分析早期人工流产女性特征、人工流产方式及相关并发症的发生情况。使用RStudio 1.1.383软件进行统计分析,采用卡方检验对研究对象基本特征进行分析。通过倾向性评分匹配方法,1∶4最邻近匹配药物流产和手术流产,并基于Logistic回归确定两组之间流产结局、不良反应和近期并发症的发生风险比值比(OR)及95%置信区间(95%CI)。结果 共纳入9 231例人工流产女性,平均年龄(28.90±5.10)岁;70.8%已婚,仅有33.9%的女性有生育史。纳入的研究对象中有9 148例资料完整,其中选择药物流产的964例(10.5%),手术流产的8 184例(89.5%)。按照药物流产与手术流产1∶4匹配后,药物流产组964例,手术流产组3 856例。倾向性评分匹配前、后手术流产组完全流产率均显著高于药物流产组[98.1%vs. 86.6%,98.2%vs. 86.6%,OR=0.11,95%CI(0.08,0.16)],匹配后手术流产组流产后包括宫腔积血(2.4%vs. 1.1%)、宫腔粘连或感染(1.1%vs. 0.2%)、月经量异常(1.2%vs. 0.4%)、流产后1~3个月腹痛(1.7%vs. 0.1%)等并发症发生率也显著高于药物流产组(P<0.05),但药物流产组流产过程疼痛评分显著高于手术流产组[(4.45±1.32)分vs.(0.55±0.99)分,P<0.01]。此外,手术流产组术中并发症发生率为4.6‰,其中主要包括人工流产综合反应和多量出血(分别为18例,各占2.2‰),0.7‰的子宫穿孔以及0.9‰的其他术中并发症。结论 手术流产完全流产率高于药物流产,但其相关并发症发生风险也高于后者。虽然各并发症发生率均低于5%,但考虑到人工流产数量和高危人群比例,其实际发生例数及危害值得关注。
Abstract:Objective:To compare the clinical use of medical abortion versus surgical abortion, as well as the complete abortion rates, adverse reactions, and the incidence of short-term complications associated with the two methods.Methods:The study was based on data from a subset of research subjects enrolled between 2019 and 2022 in the “Prospective Cohort of Female Reproductive Risks After Induced Abortion” established by the National Research Institute for Family Planning, which has been ongoing since 2019. Baseline data collection and continuous follow-up were conducted for women seeking early induced abortion, capturing their characteristics, abortion methods, and related complications. The statistical analysis was performed using RStudio 1.1.383.Chi-square tests were used to analyze the basic characteristics of the study subjects. Propensity score matching was employed with a 1∶4 nearest neighbor matching between medical and surgical abortion groups, and logistic regression was used to determine the odds ratio(OR) and 95% confidence intervals(95%CI) for abortion outcomes, adverse reactions, and the occurrence of short-term complications between the two groups.Results:A total of 9 231 women undergoing induced abortion were included in the study with a mean age of(28.90±5.10) years old. About 70.8% were married and only 33.9% had a history of childbearing. Among the study subjects, 9 148 had complete abortion records, including 964(10.5%) with medical abortion and 8 184(89.5%) with surgical abortion. After matching medical abortion and surgical abortion at a ratio of 1∶4,there were 964 cases in the medical abortion group and 3 856 cases in the surgical abortion group. Before and after propensity score matching, the complete abortion rates in the surgical abortion group were significantly higher than those in the medical abortion group[98.1% vs. 86.6%,98.2% vs. 86.6%,OR=0.11,95%CI(0.08,0.16)]. The surgical abortion group also had significantly higher incidence rates of post-abortion complications, including hematometra(2.4% vs. 1.1%),intrauterine adhesion or infection(1.1% vs. 0.2%),abnormal menstrual amount(1.2% vs. 0.4%),and abdominal pain 1 to 3 months after induced abortion(1.7% vs. 0.1%) when compared with the medical abortion group(P<0.05). However, the pain score during the abortion process was significantly higher in the medical abortion group than that in the surgical abortion group[(4.45±1.32) vs.(0.55±0.99),P<0.01]. In addition, the incidence of intraoperative complications in the surgical abortion group was 4.6‰,primarily including the induced abortion syndrome(18 cases, accounting for 2.2‰) and excessive bleeding(18 cases, accounting for 2.2‰),as well as uterine perforation(0.7‰) and other complications(0.9‰).Conclusions:The surgical abortion has a higher complete abortion rate when compared with the medical abortion, but the risk of complications is also higher. Although the incidence of complications is generally low(below 5%),the actual occurrence and harm of complications should be closely monitored, especially considering the high number of induced abortions and the proportion of high-risk populations.
[1] Kapp N,Lohr PA.Modern methods to induce abortion:Safety,efficacy and choice[J].Best Pract Res Clin Obstet Gynaecol,2020,63:37-44.
[2] 国家卫生健康委员会.2021中国卫生健康统计年鉴[M].北京:中国协和医科大学出版社,2021.
[3] Bearak JM,Popinchalk A,Beavin C,et al.Country-specific estimates of unintended pregnancy and abortion incidence:a global comparative analysis of levels in 2015-2019[J].BMJ Glob Health,2022,7:e007151.
[4] 涂鹏程,裴开颜.人工流产后早产、低出生体重和继发不孕发生风险的研究进展[J].生殖医学杂志,2020,29:268-271.
[5] 中华医学会计划生育学分会.临床诊疗指南与技术操作规范—计划生育分册(2017修订版)[M].北京:人民卫生出版社,2017.
[6] 赵雪峰.人工流产手术的麻醉现状及进展[J].中国城乡企业卫生,2021,36:40-42.
[7] 梁春梅,阮惟群,罗桂梅,等.旋动式人工流产术临床应用的安全性和有效性研究[J].局解手术学杂志,2020,29:478-481.
[8] 裴开颜.米非司酮终止妊娠的临床研究进展[J].生殖医学杂志,2015,24:766-770.
[9] 包翠禧.米非司酮分次服用方案用于早孕药物流产患者对治疗效果、起效时间及完全流产率的影响[J].中国医药指南,2024,22:114-116.
[10] 白玉,赵新玲.米非司酮联合米索前列醇在药物流产中的应用效果[J].临床研究,2023,31:65-68.
[11] Raghavan S,Comendant R,Digol I,et al.Comparison of 400 mcg buccal and 400 mcg sublingual misoprostol after mifepristone medical abortion through 63 days’ LMP:a randomized controlled trial[J].Contraception,2010,82:513-519.
[12] 林霞.药物流产与镇痛手术流产终止早孕的效果比较[J].安徽医专学报,2022,21:117-121.
[13] 王凤莲.药物流产与人工流产终止早孕的效果及对阴道出血量的影响[J].中国医药指南,2021,19:26-27.
[14] 徐爱芳,董芮.人工流产类型对再次妊娠产妇妊娠期并发症及母儿结局的影响[J].中国计划生育和妇产科,2023,15:45-48.
[15] 刘欣燕,黄薇,郁琦,等.人工流产术后促进子宫内膜修复专家共识[J].中国实用妇科与产科杂志,2021,37:322-326.
[16] 王调兰,沈翔,江琳,等.无痛人工流产手术中不同剂量甲苯磺酸瑞马唑仑镇痛镇静效果及对受术者应激反应影响[J].中国计划生育学杂志,2023,31:257-262.
[17] Baraitser P,Free C,Norman WV,et al.Improving experience of medical abortion at home in a changing therapeutic,technological and regulatory landscape:a realist review[J].BMJ Open,2022,12:e066650.
[18] Astrom M,Thet Lwin ZM,Teni FS,et al.Use of the visual analogue scale for health state valuation:a scoping review[J].Qual Life Res,2023,32:2719-2729.
[19] Tu P,Hu D,Wu S,et al.Characteristics and contraceptive practices among Chinese women seeking abortion:a multicentre,descriptive study from 2019 to 2021[J].BMJ Sex Reprod Health,2024,50:252-261.
[20] 滕萍元.米非司酮联合米索前列醇在瘢痕子宫患者早期妊娠药物流产过程中的作用分析[J].实用妇科内分泌电子杂志,2024,11:89-91.
[21] 周文英.可视吸引流产手术与传统人工流产手术效果对比[J].实用妇科内分泌电子杂志,2023,10:16-18.
[22] 罗琳.对早期妊娠患者进行无痛人工流产手术与药物流产的效果对比[J].当代医药论丛,2020,18:83-84.
[23] 吴丽雅,沈丹婷,赖淑梅.阴道B超下可视人工流产术与传统人工流产术的临床效果观察[J].中国现代药物应用,2019,13:70-71.
[24] 陈茜,徐青,陈艳.终止早期妊娠手术流产与药物流产对输卵管和子宫内膜影响的观察[J].中国计划生育学杂志,2018,26:600-602.
[25] 刘金铃.药物流产和手术流产对子宫内膜影响的比较研究[D],苏州:苏州大学,2017.
[26] 周逸雪,黄莉冰,熊万春.人工流产术后月经不调的风险预测可视化模型构建与验证[J].生殖医学杂志,2023,32:1674-1680.
[27] 蒋绍梅.不同药物治疗人工流产术后阴道流血与月经不调的疗效分析[J].实用妇科内分泌杂志(电子版),2019,6:68-71.
[28] 陈海燕,陈新,容建创.药物治疗人工流产术后阴道出血与月经不调的疗效研究[J].实用妇科内分泌杂志(电子版),2018,5:37-39.
[29] 周鑫,辛慧静,单蕊,等.米索前列醇对降低人工流产术后宫腔积血发生率的临床研究[J].实用妇科内分泌杂志(电子版),2019,6:120.
[30] Barinov SV,Tirskaya YI,Shamina IV,et al.The use of an osmotic dilator for induction of miscarriage in patients with the second trimester missed miscarriage[J].J Matern Fetal Neonatal Med,2021,34:2778-2782.
[31] Hamel CC,Snijders MPLM,Coppus SFPJ,et al.Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss[J/OL].PLoS One,2022,17:e0262894.
基本信息:
中图分类号:R169.42
引用信息:
[1]江雪,裴开颜,胡登辉,等.对比手术流产和药物流产的结局及并发症发生率:一项多中心前瞻性队列研究[J].生殖医学杂志,2025,34(05):580-587.
基金信息:
中国医学科学院医学与健康创新工程重大协同创新项目(2018-I2M-1-004); 国家卫生健康委科学技术研究所中央级公益性科研院所基本科研业务专项2021年度科技创新基金重点项目(2021GJZ02); 2023年度科技创新重大项目(2023GJZD01)
2024-12-13
2024
2025-04-23
2025
2
2025-05-15
2025-05-15